FRM
Fox Run Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,020
| Closed | -$136K | – | 956 |
|
|
2025
Q1 | $136K | Buy |
+28,020
| New | +$136K | 0.02% | 842 |
|
|
2024
Q3 | – | Sell |
-11,039
| Closed | -$75.3K | – | 873 |
|
|
2024
Q2 | $75.3K | Buy |
+11,039
| New | +$75.3K | 0.01% | 732 |
|
|
2021
Q4 | – | Sell |
-7,460
| Closed | -$374K | – | 527 |
|
|
2021
Q3 | $374K | Buy |
+7,460
| New | +$374K | 0.24% | 162 |
|
|
2020
Q4 | – | Sell |
-2,657
| Closed | -$275K | – | 212 |
|
|
2020
Q3 | $275K | Buy |
+2,657
| New | +$275K | 0.69% | 54 |
|
|
2018
Q2 | – | Sell |
-12,782
| Closed | -$673K | – | 729 |
|
|
2018
Q1 | $673K | Buy |
12,782
+5,128
| +67% | +$270K | 0.16% | 209 |
|
|
2017
Q4 | $356K | Buy |
+7,654
| New | +$356K | 0.1% | 406 |
|